D.N. Kushlinskiy

Д.Н. Кушлинский

18 articles 2011–2025

2025

Soluble forms of E-cadherin, N-cadherin and VE-cadherin in patients with ovarian cancer Technologies of Living Systems, No. 1, 2025 pp. 22-30

2023

miRNAs in the regulation of the PD-1/PD-L1 immune checkpoint in ovarian cancer Technologies of Living Systems, No. 3, 2023 pp. 55-64
Ovarian cancer and B7-H3 and B7-H4 ligands Technologies of Living Systems, No. 3, 2023 pp. 36-47
Analysis of methylation levels of miRNA genes in tumors and metastases, taking into account the concentrations of VEGF in the blood plasma of patients with ovarian cancer Technologies of Living Systems, No. 1, 2023 pp. 5-15

2021

Ovarian cancer: role and location of radiotherapy Technologies of Living Systems, No. 4, 2021 pp. 5-20

2020

Clinical implication of the programmed cell death-1 protein PD-1 and its ligand PD-L1 in ovarian cancer (review) Technologies of Living Systems, No. 3, 2020 pp. 5-15
Surgical treatment of ovarian cancer (review) Technologies of Living Systems, No. 2, 2020 pp. 18-30

2015

Insulin-like growth factors and serum igf binding proteins in ovarian tumor patients Вопросы биологической, медицинской и фармацевтической химии, No. 6, 2015 pp. 49-53

2014

Vegf signaling pathway components and matrix metalloproteinases - in tumors of patients with ovarian neoplasms Вопросы биологической, медицинской и фармацевтической химии, No. 8, 2014 pp. 47-52

2013

System of insulin-like growth factors in patients with cin and invasive cervical cancer Technologies of Living Systems, No. 4, 2013 pp. 47-52
Ovarian cancer and matrix metalloproteinases Technologies of Living Systems, No. 4, 2013 pp. 3-18
Vascular endothelial growth factor as a key angiogenesis regulator and clinically valuable marker in different malignant neoplasms Technologies of Living Systems, No. 2, 2013 pp. 18-33

2012

Prevention of abnormalities of hemostasis and vte in ovarian cancer patients, undergoing chemotherapy Technologies of Living Systems, No. 9, 2012 pp. 43-47
Angiogenic factors in ovarian cancer Technologies of Living Systems, No. 9, 2012 pp. 3-14
Vascular Endothelial Growth Factor and its Type 1 and 2 Receptors in Ovarian Tumor Patients - Serum Вопросы биологической, медицинской и фармацевтической химии, No. 10, 2012 pp. 30-35
Serum Insulin-Like Growth Factors 1 and 2 and Insulin-Like Growth Factors Binding Proteins 1 and 3 in CIN and Invasive Cervical Cancer as Perspective Markers of Disease Progression Вопросы биологической, медицинской и фармацевтической химии, No. 10, 2012 pp. 21-25

2011

Matrix Metalloproteinases in Ovarian Cancer Patients Technologies of Living Systems, No. 7, 2011 pp. 50-58матриксная мета
Clinical Prospects of Matrix Metalloproteinases and Their Tissue Inhibitors Study in Ovarian Cancer Patients Вопросы биологической, медицинской и фармацевтической химии, No. 10, 2011 pp. 27-36